a beta blocker used as eye drops in the treatment of glaucoma; side-effects may include local stinging and burning.
Trade names:

The new mediacal dictionary. 2014.

Look at other dictionaries:

  • Levobunolol — Identificadores Código ATC  ? Datos químicos …   Wikipedia Español

  • Levobunolol — Strukturformel Allgemeines Freiname Levobunolol …   Deutsch Wikipedia

  • Levobunolol — drugbox IUPAC name = 5 (2 hydroxy 3 tert butylamino propoxy) tetralin 1 one CAS number = 47141 42 4 ATC prefix = S01 ATC suffix = ED03 ATC supplemental = PubChem = 39468 DrugBank = APRD00165 C=17 | H=25 | N=1 | O=3 molecular weight = 291.385… …   Wikipedia

  • levobunolol — Eng. Levobunolol Betabloqueante con características comparables a las del timolol …   Diccionario de oftalmología

  • levobunolol — n. a beta blocker used as eye drops in the treatment of glaucoma; side effects may include local stinging and burning. Trade name: Betagan …   Medical dictionary

  • levobunolol hydrochloride — A β adrenergic blocking agent used primarily as an eye drop in the treatment of chronic open angle glaucoma and ocular hypertension. * * * le·vo·bu·no·lol hy·dro·chlo·ride (le″vo buґno lol) a nonspecific beta adrenergic blocking agent… …   Medical dictionary

  • clorhidrato de levobunolol — Fármaco oftálmico tópico que se prescribe para el tratamiento del glaucoma de ángulo abierto y para la hipertensión ocular. Diccionario Mosby Medicina …   Diccionario médico

  • Beta blocker — Beta blockers Drug class Skeletal formula of propranolol, the first clinically successful beta blocker ATC code C07 …   Wikipedia

  • Guanethidine — Systematic (IUPAC) name 2 [2 (azocan 1 yl)ethyl]guanidine Clinical data AHFS/Drugs.com …   Wikipedia

  • Clonidine — Not to be confused with clomifene or Klonopin. Clonidine Systematic (IUPAC) name N (2,6 dichlorophenyl) 4,5 dihydro 1H imidazol 2 amine …   Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”

We are using cookies for the best presentation of our site. Continuing to use this site, you agree with this.